Opportunity ID: 325997

General Information

Document Type: Grants Notice
Funding Opportunity Number: PAR-20-161
Funding Opportunity Title: Catalyzing Innovation in Pediatric Pharmacology Clinical Trial Design and Resource Access (X01 Clinical Trial Not Allowed)
Opportunity Category: Discretionary
Opportunity Category Explanation:
Funding Instrument Type: Grant
Category of Funding Activity: Health
Income Security and Social Services
Category Explanation:
Expected Number of Awards:
Assistance Listings: 93.865 — Child Health and Human Development Extramural Research
Cost Sharing or Matching Requirement: No
Version: Synopsis 1
Posted Date: Apr 02, 2020
Last Updated Date: Apr 02, 2020
Original Closing Date for Applications: Mar 17, 2023
Current Closing Date for Applications: Mar 17, 2023
Archive Date: Apr 22, 2023
Estimated Total Program Funding:
Award Ceiling:
Award Floor:

Eligibility

Eligible Applicants: County governments
Small businesses
Special district governments
Public and State controlled institutions of higher education
For profit organizations other than small businesses
Native American tribal organizations (other than Federally recognized tribal governments)
Nonprofits having a 501(c)(3) status with the IRS, other than institutions of higher education
Nonprofits that do not have a 501(c)(3) status with the IRS, other than institutions of higher education
Public housing authorities/Indian housing authorities
Independent school districts
Others (see text field entitled “Additional Information on Eligibility” for clarification)
Private institutions of higher education
City or township governments
State governments
Native American tribal governments (Federally recognized)
Additional Information on Eligibility: Other Eligible Applicants include the following: Alaska Native and Native Hawaiian Serving Institutions; Asian American Native American Pacific Islander Serving Institutions (AANAPISISs); Eligible Agencies of the Federal Government; Faith-based or Community-based Organizations; Hispanic-serving Institutions; Historically Black Colleges and Universities (HBCUs); Indian/Native American Tribal Governments (Other than Federally Recognized); Non-domestic (non-U.S.) Entities (Foreign Organizations); Regional Organizations; Tribally Controlled Colleges and Universities (TCCUs) ; U.S. Territory or Possession; Non-domestic (non-U.S.) Entities (Foreign Institutions) are not eligible to apply. Non-domestic (non-U.S.) components of U.S. Organizations are not eligible to apply. Foreign components, as defined in the NIH Grants Policy Statement, are allowed.

Additional Information

Agency Name: National Institutes of Health
Description: The purpose of this funding opportunity announcement (FOA) is to provide investigators with access to a consultative resource for planning activities and concept development for single or multi-site investigator initiated clinical trials that address gaps in pediatric drug development and that align with priorities identified in the Best Pharmaceuticals for Children Act (BPCA) Program. The FOA will support the development of clinical trials concepts of future well-designed clinical trials that require non-traditional designs in pediatric therapeutics with the opportunity to expand novelty and/or innovation. Investigators will have access to the expertise in pediatric drug development trial designs by utilizing the consultative services provided by the Pediatric Trials Network (PTN) and the BPCA Data Coordinating Center.
Link to Additional Information: http://grants.nih.gov/grants/guide/pa-files/PAR-20-161.html
Grantor Contact Information: If you have difficulty accessing the full announcement electronically, please contact:

NIH OER Webmaster
FBOWebmaster@OD.NIH.GOV
Email:FBOWebmaster@OD.NIH.GOV

Version History

Version Modification Description Updated Date

Folder 325997 Full Announcement-PAR-20-161 -> PAR-20-161-Full-Announcement.pdf

Packages

Agency Contact Information: NIH OER Webmaster
FBOWebmaster@OD.NIH.GOV
Email: FBOWebmaster@OD.NIH.GOV
Who Can Apply: Organization Applicants

Assistance Listing Number Competition ID Competition Title Opportunity Package ID Opening Date Closing Date Actions
FORMS-F Use for due dates on or before January 24, 2022 PKG00260723 Aug 14, 2020 Jan 24, 2022 View
FORMS-G Use for due dates on or before January 24, 2023 PKG00270572 Nov 22, 2021 Jan 24, 2023 View
FORMS-H Use for due dates on or after January 25, 2023 PKG00278503 Nov 16, 2022 Mar 17, 2023 View

Package 1

Mandatory forms

325997 RR_SF424_2_0-2.0.pdf

325997 PHS398_CoverPageSupplement_5_0-5.0.pdf

325997 RR_OtherProjectInfo_1_4-1.4.pdf

325997 RR_KeyPersonExpanded_2_0-2.0.pdf

325997 PHS398_ResearchPlan_4_0-4.0.pdf

325997 PHSHumanSubjectsAndClinicalTrialsInfo_2_0-2.0.pdf

Optional forms

325997 PHS_AssignmentRequestForm_3_0-3.0.pdf

Package 2

Mandatory forms

325997 RR_SF424_5_0-5.0.pdf

325997 PHS398_CoverPageSupplement_5_0-5.0.pdf

325997 RR_OtherProjectInfo_1_4-1.4.pdf

325997 RR_KeyPersonExpanded_4_0-4.0.pdf

325997 PHS398_ResearchPlan_4_0-4.0.pdf

325997 PHSHumanSubjectsAndClinicalTrialsInfo_3_0-3.0.pdf

Optional forms

325997 PHS_AssignmentRequestForm_3_0-3.0.pdf

Package 3

Mandatory forms

325997 RR_SF424_5_0-5.0.pdf

325997 PHS398_CoverPageSupplement_5_0-5.0.pdf

325997 RR_OtherProjectInfo_1_4-1.4.pdf

325997 RR_KeyPersonExpanded_4_0-4.0.pdf

325997 PHS398_ResearchPlan_5_0-5.0.pdf

325997 PHSHumanSubjectsAndClinicalTrialsInfo_3_0-3.0.pdf

Optional forms

325997 PHS_AssignmentRequestForm_3_0-3.0.pdf

2025-07-09T16:14:17-05:00

Share This Post, Choose Your Platform!

About the Author: